|
| Press Releases |
|
 |
|
| Thursday, September 8, 2022 |
|
|
Dammam Valley and Arcensus GmbH to establish Saudi-German Genomic Center in Riyadh |
| The Saudi-German Genomic Center will start operationally with immediate activity and provide comprehensive genomic diagnostic services for the GCC region based on exclusive next-generation sequencing technologies. more info >> |
|
|
Dammam Valley and Arcensus GmbH announce establishment of the Saudi-German Genomic Center in Riyadh |
| Dammam Valley in partnership with other investment partners, and Arcensus GmbH/Germany, announce the establishment of a high-throughput Saudi-German Genomic Center in Riyadh. more info >> |
|
| Monday, September 5, 2022 |
|
|
Dammam Valley to acquire majority in Arcensus GmbH; accelerating Whole Genome Sequencing in genetic diagnostics, delivering breakthrough technologies in genomic bioinformatics |
| Dammam Valley in partnership with other investment partners, announce to acquire a majority stake in Arcensus GmbH/Germany. Arcensus, founded by Dr. Arndt Rolfs, a multi-entrepreneur in biotechnology, CEO and founder of several innovative biotech companies, is a digital health and diagnostics company providing comprehensive genomic diagnostic services based on Whole Genome Sequencing. more info >> |
|
| Tuesday, February 22, 2022 |
|
|
MBMV invests in international bio-tech startup Arcensus GmbH |
| Based on Whole Genome Sequencing (WGS) Arcensus GmbH, Rostock/Berlin/New Jersey makes it possible to detect rare as well as frequent disorders such as cancer or heart diseases at the earliest stage in order to start preventive and personalized treatment. more info >> |
|
| Wednesday, January 12, 2022 |
|
|
Arcensus has appointed Prof. Dr. Arndt Rolfs as New CEO |
| Arcensus, a commercial-stage digital healthcare and diagnostics company that empowers people to take control of their health is pleased to announce that our Founder, Prof. Dr. Arndt Rolfs, a multi-entrepreneur in biotech and former CEO of several innovative biotech companies, including Nasdaq-listed company CENTOGENE, has been appointed as the Chief Executive Officer of Arcensus GmbH. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Icarus' Future: A Miami-Born Campaign Telling COP30 Leaders Our Children's Future is at Stake - Just Won Seven LUUM Awards
Nov 18, 2025 08:00 HKT/SGT
|
|
|
Radisson Announces Exercise of Warrants
Nov 18, 2025 06:29 HKT/SGT
|
|
|
Mazda Begins Demonstration Experiment of Onboard CO2 Capture System
Nov 17, 2025 0:38 JST
|
|
|
Pushing Hydrogen Engine Technology to New Heights in the Super Taikyu Series Final Race
Nov 17, 2025 0:00 JST
|
|
|
Graid Technology 完成與英特爾 VROC 的授權協議，拓展其在企業儲存解決方案領域的領導地位
Nov 17, 2025 23:00 HKT/SGT
|
|
|
OBI-902、米国FDAより胆管癌治療を対象とした希少疾病用医薬品指定を取得
Nov 17, 2025 23:00: JST
|
|
|
Fujitsu launches business creation lab in collaboration with AWS Japan
Nov 17, 2025 23:41 JST
|
|
|
NTT DOCOMO Achieves Successful Outdoor Trial of AI-Driven Wireless Interface Toward 6G
Nov 17, 2025 23:05 JST
|
|
|
Graid Technology Finalizes Intel VROC Licensing Agreement, Expanding Leadership in Enterprise Storage Solutions
Nov 17, 2025 22:00 HKT/SGT
|
|
|
JBM Healthcare Announces FY2026 Interim Results
Nov 17, 2025 21:43 HKT/SGT
|
|
|
健倍苗苗公佈二零二六財政年度中期業績
Nov 17, 2025 21:43 HKT/SGT
|
|
|
健倍苗苗公布二零二六财政年度中期业绩
Nov 17, 2025 21:43 HKT/SGT
|
|
|
Destinator Earns the Highest Rating of Five Stars in 2025 ASEAN NCAP
Nov 17, 2025 22:32 JST
|
|
|
"LEQEMBI(R)" (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease Approved in the United Kingdom
Nov 17, 2025 22:08 JST
|
|
|
OBI-902 has been granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma
Nov 17, 2025 21:00: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
